These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22682291)

  • 1. Intradermal immunization using coated microneedles containing an immunoadjuvant.
    Andrianov AK; Mutwiri G
    Vaccine; 2012 Jun; 30(29):4355-60. PubMed ID: 22682291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedles with intrinsic immunoadjuvant properties: microfabrication, protein stability, and modulated release.
    Andrianov AK; Marin A; DeCollibus DP
    Pharm Res; 2011 Jan; 28(1):58-65. PubMed ID: 20372988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
    Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal powder immunization with protein-containing vaccines.
    Weissmueller NT; Schiffter HA; Pollard AJ
    Expert Rev Vaccines; 2013 Jun; 12(6):687-702. PubMed ID: 23750797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
    Chen MC; Huang SF; Lai KY; Ling MH
    Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery.
    Häfeli UO; Mokhtari A; Liepmann D; Stoeber B
    Biomed Microdevices; 2009 Oct; 11(5):943-50. PubMed ID: 19347587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents.
    Eng NF; Garlapati S; Gerdts V; Potter A; Babiuk LA; Mutwiri GK
    Curr Drug Deliv; 2010 Jan; 7(1):13-20. PubMed ID: 19863483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
    Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge.
    Romanyuk A; Wang R; Marin A; Janus BM; Felner EI; Xia D; Goez-Gazi Y; Alfson KJ; Yunus AS; Toth EA; Ofek G; Carrion R; Prausnitz MR; Fuerst TR; Andrianov AK
    J Funct Biomater; 2022 Dec; 14(1):. PubMed ID: 36662063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
    Safari D; Dekker HA; Rijkers G; Snippe H
    Vaccine; 2011 Jan; 29(4):849-54. PubMed ID: 21111776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical administration of microneedles: skin puncture, pain and sensation.
    Haq MI; Smith E; John DN; Kalavala M; Edwards C; Anstey A; Morrissey A; Birchall JC
    Biomed Microdevices; 2009 Feb; 11(1):35-47. PubMed ID: 18663579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array.
    Ding Z; Bal SM; Romeijn S; Kersten GF; Jiskoot W; Bouwstra JA
    Pharm Res; 2011 Jan; 28(1):145-58. PubMed ID: 20237826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery.
    Payne LG; Jenkins SA; Andrianov A; Roberts BE
    Pharm Biotechnol; 1995; 6():473-93. PubMed ID: 7551232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
    Berner VK; Sura ME; Hunter KW
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-Functionalized Polyphosphazene Immunoadjuvant: Synthesis, Solution Behavior and In Vivo Potency.
    Tagad HD; Marin A; Wang R; Yunus AS; Fuerst TR; Andrianov AK
    Molecules; 2023 May; 28(10):. PubMed ID: 37241958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.